CoChat

Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders

Open access
Lee, Chien-Hsing, Hung, Shih-Ya · 2022 · Pharmaceutics

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Abstract

Accumulating data suggest that α7 nicotinic acetylcholine receptors (α7nAChRs) are an important therapeutic target for the treatment of Alzheimer’s disease (AD) and schizophrenia. The homopentameric ligand-gated ion channel α7nAChR consists of five identical α7 subunits that are encoded by the CHRNA7 (cholinergic receptor nicotinic alpha7 subunit) gene. Moreover, α7nAChRs are densely distributed throughout the hippocampus, cortex, and thalamus brain regions, but sparsely in the striatum, forebrain, and medulla. Compared with other nAChRs, α7nAChR binds with low affinity to the naturally occurring neurotransmitter acetylcholine and the non-specific exogenous agonist nicotine, and with high affinity to the specific antagonists α-bungarotoxin and methyllycaconitine. Reports indicate that α7nAChR plays important roles in neurotransmitter release, cognitive functioning, and the cholinergic anti-inflammatory response. Genetic variations that alter CHRNA7 mRNA and protein expression or cause α7nAChR dysfunction are associated with many brain disorders. Our previous studies revealed that α7nAChR exerts neuroprotection in AD by acting as a cargo receptor for binding the autophagosomal marker protein LC3 and engulfing extracellular neurotoxic Aβ1–42 during autophagic degradation of the α7nAChR-Aβ1–42 complex. However, the role of α7nAChRs in other diseases remains unknown. Here, we review and summarize the essential characteristics and current findings concerning α7nAChRs in four common brain diseases (AD, Parkinson’s disease, schizophrenia, and depression), which may elucidate the role of α7nAChRs and inform innovative research and novel treatments that target α7nAChRs in brain disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics15010031

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Classification of cholinergic receptors and subunits of neuronal nicotinic acetylcholine receptors (nAChRs). (A) Cholinergic receptors contain nicotinic and muscarinic acetylcholine receptors. (B) Neuronal subunits of neuronal nAChRs in mammalians (α8 is cloned from the chicken brain).
Figure 1 Classification of cholinergic receptors and subunits of neuronal nicotinic acetylcholine receptors (nAChRs). (A) Cholinergic receptors contain nicotinic and muscarinic acetylcholine receptors. (B) Neuronal subunits of neuronal nAChRs in mammalians (α8 is cloned from the chicken brain).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 95 references

Cited by

See all 50

Metadata

Authors
Lee, C.-H., & Hung, S.-Y.
Affiliations
  • Kaohsiung Medical University (TW)
  • China Medical University (TW)
Corresponding author
Hung, Shih-Ya
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2022-12-22
Volume
15
Issue
1
Pages
31
ISSN
1999-4923 (ISSN-L)
OpenAlex
W4312117327
Cited by
50
References
94
Citations by year
2026: 12 · 2025: 21 · 2024: 12 · 2023: 5
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • the Ministry of Science and Technology of Taiwan (MOST 111-2320-B-039-044-MY3, MOST 110-2811-B-039-509, CMU109-S-28)
  • China Medical University (MOST 111-2320-B-039-044-MY3, MOST 110-2811-B-039-509, CMU109-S-28)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
alpha7 nicotinic acetylcholine receptor, CHRNA7, Alzheimer's disease, schizophrenia, Parkinson's disease, depression, autophagy, amyloid-beta clearance, neuroprotection, neurotransmitter release, cognitive function, ligand-gated ion channels, alpha-bungarotoxin, methyllycaconitine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders. https://app.cochat.ai/papers/10.3390/pharmaceutics15010031
The paper
Lee, C.-H., & Hung, S.-Y. (2022). Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15010031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.